
Daniel Dilling MD FACP, FAST, FCCP
Critical Care Medicine, Interstitial Lung Diseases, Lung Transplantation Medicine
Professor of Medicine, Medical Director, Lung and Heart-Lung Transplant, Pulmonary and Critical Care, Loyola University Medical Center
Join to view full profile
2160 S First AveMaywood, IL 60153
Phone+1 708-327-2181
Fax+1 708-327-2424
Dr. Dilling is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Daniel Dilling is Professor of Medicine, Loyola University Chicago, Stritch School of Medicine and a pulmonologist affiliated with Loyola University Medical Center. He received his medical degree from Loyola University Chicago Stritch School of Medicine (where he also trained) and has been in practice since 2005. He specializes in the care of patients with lung transplants, interstitial lung diseases, idiopathic pulmonary fibrosis, lymphangioleiomyomatosis (LAM), and other rare lung diseases.
Education & Training
Loyola University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2005
Loyola University Medical CenterResidency, Internal Medicine, 1998 - 2001
Loyola University Medical CenterInternship, Internal Medicine, 1998 - 1999
Loyola University Chicago Stritch School of MedicineClass of 1998
University of Notre DameB.A., Anthropology and Preprofessional Studies, 1994
Certifications & Licensure
IL State Medical License 2001 - 2029
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
Awards, Honors, & Recognition
- Distinguished CHEST Educator American College of Chest Physicians, 2021-2022
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
Clinical Trials
- Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial Start of enrollment: 2018 Jan 01
- A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension Start of enrollment: 2020 Dec 14
Publications & Presentations
PubMed
- 1 citationsUtility of donor-derived cell-free DNA testing after lung transplantation in the precision medicine era.Brian C Keller, Sean Agbor-Enoh, Michael B Keller, Sravanthi Nandavaram, Adriana Zeevi
The Journal of Heart and Lung Transplantation. 2026-08-01 - CD26/DPP-IV inhibitors and associations with chronic lung allograft dysfunction in a multicenter cohort.Alexander R Graham, Maria V Grau-Sepulveda, Erika J Bush Buckley, Daniel F Dilling, Albert Faro
The Journal of Heart and Lung Transplantation. 2025-09-01 - 8 citationsNorth American expert consensus on the clinical role of ex vivo lung perfusion (EVLP) with acellular perfusate.Matthew Bacchetta, Christian A Bermudez, Ankit Bharat, A Whitney Brown, Marie M Budev
Journal of Thoracic Disease. 2025-04-30
Journal Articles
- First Spontaneous Pneumothorax: Time for Screening High-Resolution Computed Tomographic Imaging to Look for Cystic Lung Disease?Dilling DF, Ann Am Thorac Soc, 1/1/2017
- Alpha-N-acetyl-neuraminide alpha-2, 8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in miceEby, J, Barse L, Henning SW, Rabelink JWE, Klarquist J, Gilbert ER, Hammer AM, Fernandez MF, Yung N, Khan S, Miller HG, Kessler ER, Garrett-Mayer E, Dilling DF, Hoeben..., Cancer Immunology, Immunotherapy, 1/1/2016
- ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipientsGottlieb J, Zamora MR, Hodges T, Dilling D, et al, J Heart Lung Transplant, 1/1/2016
Books/Book Chapters
Abstracts/Posters
- "Placental Transmogrification Of The Lung Mimicking Lymphangioleiomyomatosis"Dilling DF, International Rare Lung Diseases Research Conference and LAMposium, Covington, KY, 1/1/2016
- De Novo Anti-HLA Class II Donor Specific Antibodies after Lung Transplantation Are Associated with Mortality after Lung Transplant Failure.Bahar B, Dilling DF, Du Z, Journal of Heart and Lung Transplantation (JHLT), 1/1/2016
- Placental Transmogrification Of the Lung Mimicking Lymphangioleiomyomatosis.Fernandez Castillo JC, Dilling DF, American Journal of Respiratory and Critical Care Medicine (AJRCCM), 1/1/2016
Lectures
- "Approach to Pneumothorax and Pleurodesis"Covington, KY - 1/1/2016
- "Preventing Damage in COPD: Focusing on Alpha-1 Antitrypsin Deficiency"Waukegan, IL - 1/1/2016
- "COPD: Take a Fresh Look at an Increasing Problem"Waukegan, IL - 1/1/2016
Other
- Diagnostic criteria for persistent vegetative state.Dilling DF, Virtual Mentor
http://www.ama-assn.org/ama1/pub/upload/mm/384/17516-cprl1.pdf
1/1/2007
Authored Content
- Reflecting on CHEST 2021November 2021
Press Mentions
Two-Time Lung Transplant Recipient to Participate in Hustle Chicago ClimbMarch 19th, 2026
Steering Committee of Pulmonary and Primary Care Experts Aims to Reduce Time to Diagnose Complex Lung DiseasesMay 17th, 2022
Steering Committee of Pulmonary and Primary Care Experts Aims to Reduce Time to Diagnose Complex Lung DiseasesMay 17th, 2022
Professional Memberships
- Fellow
- Member
- Fellow
- Member
- International Society of Heart and Lung TransplantationMember
Other Languages
- Spanish
External Links
- Loyola Profilehttp://www.loyolamedicine.org/find_doctor/doctor_profile.cfm?seq_cntr=3063
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:








